Loading...

Purified anti-human CD3 Antibody

Pricing & Availability
Clone
UCHT1 (See other available formats)
Regulatory Status
RUO
Workshop
III 471
Other Names
T3, CD3ε
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_UCHT1_Purified_021805
Human peripheral blood lymphocytes stained with purified UCHT1 and then detected with anti-mouse IgGs FITC
  • 1_UCHT1_Purified_021805
    Human peripheral blood lymphocytes stained with purified UCHT1 and then detected with anti-mouse IgGs FITC
  • 2_UCHT1_PURE_CD3_Antibody_IHC-F_090718
    Human frozen spleen tissue slices were fixed with 4% PFA for ten minutes and blocked with 5% FBS for 30 minutes. Then, the tissue was stained with 10 µg/mL of purified anti-human CD3 antibody (clone UCHT1, red) overnight at 4°C. On the next day, tissue was incubated with Alexa Fluor® 594 Goat anti-mouse IgG (clone Poly4053, red). Nuclei were counter-stained with DAPI (blue). The image was scanned with a 10X objective and stitched with MetaMorph® software.
Compare all formats
Cat # Size Price Quantity Check Availability Save
300401 25 µg $24
Check Availability


Need larger quantities of this item?
Request Bulk Quote
300402 100 µg $44
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD chain of the CD3/T-cell receptor (TCR) complex which is composed of two CD3ε, one CD3γ, one CD3δ, one CD3ζ (CD247), and a T-cell receptor (α/β or γ/δ) heterodimer. It is found on all mature T cells, NKT cells, and some thymocytes. CD3, also known as T3, is a member of the immunoglobulin superfamily that plays a role in antigen recognition, signal transduction, and T cell activation.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Human
Reported Reactivity
Chimpanzee
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
CyTOF®, IHC-F - Verified
IP, Activ, WB - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per million cells in 100 µl volume. For immunohistochemistry, a concentration range of 5.0 - 10 µg/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections4,6,7 and formalin-fixed paraffin-embedded sections11, immunoprecipitation1, activation of T cells2,3,5, Western blotting9, and spatial biology (IBEX)16,17. The LEAF™ purified antibody (Endotoxin < 0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 300413, 300414, and 300432). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 300437, 300438, 300465, 300466, 300473, 300474) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Salmeron A, et al. 1991. J. Immunol. 147:3047. (IP)
  2. Graves J, et al. 1991. J. Immunol. 146:2102. (Activ)
  3. Lafont V, et al. 2000. J. Biol. Chem. 275:19282. (Activ)
  4. Ryschich E, et al. 2003. Tissue Antigens 62:48. (IHC)
  5. Thompson AG, et al. 2004. J. Immunol. 173:1671. (Activ)
  6. Sakkas LI, et al. 1998. Clin. Diagn. Lab. Immun. 5:430. (IHC)
  7. Mack CL, et al. 2004. Pediatr. Res. 56:79. (IHC)
  8. Thakral D, et al. 2008. J. Immunol. 180:7431. (FC) PubMed
  9. Van Dongen JJM, et al. 1988. Blood 71:603. (WB)
  10. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  11. Pollard, K. et al. 1987. J. Histochem. Cytochem. 35:1329. (IHC)
  12. Luckashenak N, et al. 2013. J. Immunol. 190:27. PubMed
  13. Laurent AJ, et al. 2014. PLoS One. 9:103683. PubMed
  14. Li J, et al. 2015. Cancer Res. 75:508. PubMed
  15. Stoeckius M, et al. 2017. Nat. Methods. 14:865-868. (PG)
  16. Radtke AJ, et al. 2020. Proc Natl Acad Sci USA. 117:33455-33465. (SB) PubMed
  17. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
  2. Mousset CM, et al. 2018. Oncoimmunology. 7:e1488565. PubMed
  3. Rouers A, et al. 2021. Cell Rep Med. 2:100278. PubMed
  4. Özcan A, et al. 2020. J Invest Dermatol. 1003:140. PubMed
  5. Laurent A, et al. 2014. PLoS One. 9:103683. PubMed
  6. Alroqi F, et al. 2017. J Clin Immunol. . 10.1007/s10875-017-0451-1. PubMed
  7. Wagner J et al. 2019. Cell. 177(5):1330-1345 . PubMed
  8. Nguyen LT, et al. 2019. Cancer Immunol Immunother. 68:773. PubMed
  9. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  10. Korn MA, et al. 2020. J Immunol. 205:2595. PubMed
  11. González-Mancha N, et al. 2022. Front Immunol. 12:814570. PubMed
  12. Webb LMC, et al. 2021. Aging Cell. 20:e13295. PubMed
  13. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  14. Fasbender F, et al. 2017. Front Immunol. 0.88125. PubMed
  15. Kollis PM, et al. 2022. Front Immunol. 13:850226. PubMed
  16. Tocheva AS, et al. 2020. J Biol Chem. 295:18036. PubMed
  17. Santos R, et al. 2017. Nat Commun. . 10.1038/s41467-017-01760-5. PubMed
  18. Bobardt M, et al. 2020. PLoS One. 15:e0227715. PubMed
  19. Song C, et al. 2022. Stem Cell Res Ther. 13:48. PubMed
  20. Alcántara-Hernández M, et al. 2021. Nat Protoc. 16:4855. PubMed
  21. Mann ER, et al. 2020. Sci Immunol. :5. PubMed
  22. Tian Y, et al. 2019. Cell Rep. 29:4482. PubMed
  23. Wang C, et al. 2022. Exp Ther Med. 23:221. PubMed
  24. Coelho CH, et al. 2020. JCI Insight. 5:. PubMed
  25. Cribbs AP, et al. 2021. Front Immunol. 12:626255. PubMed
  26. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  27. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
  28. Gunawan M, et al. 2017. Sci Rep. . 10.1038/s41598-017-16999-7. PubMed
  29. Guo T, et al. 2018. J Immunol. 200:500. PubMed
  30. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  31. Martin JC, et al. 2020. Cell. 178(6):1493-1508.e20.. PubMed
  32. Michlmayr D, et al. 2020. Cell Reports. 31(4):107569. PubMed
  33. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  34. Eldredge LC, et al. 2019. Am J Physiol Lung Cell Mol Physiol. 317:L49. PubMed
  35. Hejazi M, et al. 2022. Front Immunol. 12:798087. PubMed
  36. Khanolkar A, et al. 2020. Immunohorizons. 4:153. PubMed
  37. Speir M,et al. 2017. Sci Rep.. 10.1038/s41598-017-14690-5. PubMed
  38. Agrawal N, et al. 2018. Front Immunol. 2.053472222. PubMed
  39. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  40. Del Alcazar D, et al. 2019. Cell Rep. 28:3047. PubMed
  41. Jakob M, et al. 2020. Cells. 10:. PubMed
  42. Tocheva AS, et al. 2020. J Biol Chem. 295:18036. PubMed
  43. Wright CC, et al. 2017. Infect Immun. 85:e00131. PubMed
  44. Hunter S, et al. 2018. J Hepatol. 69:654. PubMed
  45. Guerrero A, et al. 2012. J Immunol. 190:27. PubMed
  46. Chng MHY, et al. 2020. Immunity. 51(6):1119-1135.e5.. PubMed
  47. Hartmann FJ, et al. 2019. Cell Rep. 28:819. PubMed
  48. Roussel M, et al. 2021. Cell Reports Medicine. 2(6):100291. PubMed
  49. Bengsch B et al. 2018. Immunity. 48(5):1029-1045 . PubMed
  50. Evrard M et al. 2018. Immunity. 48(2):364-379 . PubMed
  51. Silva–Cardoso SC, et al. 2017. J Immunol. 199:253. PubMed
  52. Tang JS, et al. 2020. Food Funct. 11:5782. PubMed
  53. Mishra A, et al. 2021. Cell. 184(13):3394-3409.e20. PubMed
  54. Schwabenland M, et al. 2021. Immunity. . PubMed
  55. Thompson A, et al. 2004. J Immunol. 173:1671. PubMed
  56. Oda H, et al. 2019. Front Immunol. 10:479. PubMed
  57. Manes TL, et al. 2020. Free Radic Biol Med. 147:102. PubMed
  58. Kennedy-Darling J, et al. 2021. Eur J Immunol. 51:1262. PubMed
  59. Han M, et al. 2022. Cell Mol Immunol. 19:805. PubMed
  60. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
  61. Crawford LB, et al. 2021. J Virol. 95:. PubMed
  62. Ainai A, et al. 2020. Microbiol Immunol. 64:313. PubMed
  63. Yamaguchi K, et al. 2018. Cancer Sci. 109:3032. PubMed
  64. Lavin Y et al. 2017. Cell. 169(4):750-765 . PubMed
  65. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  66. Kim ML, et al. 2021. iScience. 24:103509. PubMed
  67. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  68. Martin E, et al. 2020. JCI Insight. :5. PubMed
  69. Li J, et al. 2015. Cancer Res. 75:508. PubMed
RRID
AB_314055 (BioLegend Cat. No. 300401)
AB_314056 (BioLegend Cat. No. 300402)

Antigen Details

Structure
Ig superfamily, with the subunits of CD3γ, CD3δ, CD3ζ (CD247) and TCR (α/β or γ/δ) forms CD3/TCR complex, 20 kD
Distribution

Mature T and NK T cells, thymocyte differentiation

Function
Antigen recognition, signal transduction, T cell activation
Ligand/Receptor
Peptide antigen bound to MHC
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology, Innate Immunity
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay N, et al. 1993. The Leucocyte FactsBook. Academic Press. San Diego.
2. Beverly P, et al. 1981. Eur. J. Immunol. 11:329.
3. Lanier L, et al. 1986. J. Immunol. 137:2501-2507.

Gene ID
916 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-human CD3 UCHT1 FC
Biotin anti-human CD3 UCHT1 FC
FITC anti-human CD3 UCHT1 FC
PE anti-human CD3 UCHT1 FC
PE/Cyanine5 anti-human CD3 UCHT1 FC
Purified anti-human CD3 UCHT1 FC,CyTOF®,IHC-F,IP,Activ,WB
Alexa Fluor® 647 anti-human CD3 UCHT1 FC,ICC,IHC-F
Alexa Fluor® 488 anti-human CD3 UCHT1 FC,ICC,IHC-F
Pacific Blue™ anti-human CD3 UCHT1 FC
PE/Cyanine7 anti-human CD3 UCHT1 FC
Alexa Fluor® 700 anti-human CD3 UCHT1 FC
APC/Cyanine7 anti-human CD3 UCHT1 FC
PerCP anti-human CD3 UCHT1 FC
PerCP/Cyanine5.5 anti-human CD3 UCHT1 FC
Brilliant Violet 421™ anti-human CD3 UCHT1 FC,ICC,IHC-F
Brilliant Violet 570™ anti-human CD3 UCHT1 FC
Ultra-LEAF™ Purified anti-human CD3 UCHT1 FC,CyTOF®,IHC-F,IP,Activ,WB
Purified anti-human CD3 (Maxpar® Ready) UCHT1 FC,CyTOF®
Alexa Fluor® 594 anti-human CD3 UCHT1 ICC,FC,SB
PE/Dazzle™ 594 anti-human CD3 UCHT1 FC
Brilliant Violet 510™ anti-human CD3 UCHT1 FC
Brilliant Violet 605™ anti-human CD3 UCHT1 FC
Brilliant Violet 711™ anti-human CD3 UCHT1 FC
Brilliant Violet 650™ anti-human CD3 UCHT1 FC
APC/Fire™ 750 anti-human CD3 UCHT1 FC
Pacific Blue™ anti-human CD3 UCHT1 FC
Brilliant Violet 785™ anti-human CD3 UCHT1 FC
PE/Dazzle™ 594 anti-human CD3 UCHT1 FC
TotalSeq™-A0034 anti-human CD3 UCHT1 PG
TotalSeq™-B0034 anti-human CD3 UCHT1 PG
TotalSeq™-C0034 anti-human CD3 UCHT1 PG
PE anti-human CD3 UCHT1 FC
PE/Cyanine7 anti-human CD3 UCHT1 FC
KIRAVIA Blue 520™ anti-human CD3 UCHT1 FC
Spark Violet™ 538 anti-human CD3 Antibody UCHT1 FC
TotalSeq™-D0034 anti-human CD3 UCHT1 PG
Spark Blue™ 574 anti-human CD3 Antibody UCHT1 FC
GMP Pacific Blue™ anti-human CD3 UCHT1 FC
GMP PE anti-human CD3 UCHT1 FC
GMP PE/Dazzle™ 594 anti-human CD3 UCHT1 FC
Spark Violet™ 423 anti-human CD3 UCHT1 FC
GMP PE/Cyanine7 anti-human CD3 UCHT1 FC
Spark Blue™ 515 anti-human CD3 UCHT1 FC
Go To Top Version: 3    Revision Date: 09/01/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account